Discontinued — last reported Q2 '24

Current Liabilities

Accrued Manufacturing Costs

Polaryx Therapeutics, Inc. Accrued Manufacturing Costs remained flat by 0.0% to $21.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionCurrent Liabilities
First reportedQ4 2015
Last reportedQ2 2024
Metric ID: accrued_manufacturing_costs

Historical Data

2 periods
 Q4 '25Q1 '26
Value$21.00K$21.00K
QoQ Change—+0.0%
Range$21.00K – $21.00K

Frequently Asked Questions

What is Polaryx Therapeutics, Inc. 's accrued manufacturing costs?
Polaryx Therapeutics, Inc. (PLYX) reported accrued manufacturing costs of $21.00K in Q1 2026.